末梢血管インターベンション機器の世界市場分析・予測...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 Catalyst 13
2.2 Related Reports 14
3 Market Access 15
3.1 Reimbursement Trends 15
3.1.1 North America 15
3.1.2 Europe 19
3.1.3 Asia-Pacific 21
3.1.4 South America 23
3.2 Mergers and Acquisitions/Key Partnerships 24
4 Unmet Needs and Market Opportunity Analysis 26
4.1 High Quality Data for Drug-eluting Balloons in Specific Indications 26
4.2 Minimizing Periprocedural Stroke Risk During Carotid Artery Interventions 27
4.2.1 Anti-thrombotic Coatings 27
4.2.2 Occlusion with Flow Reversal 27
4.2.3 Integrated Embolic Protection 28
4.3 Motorized Delivery Systems 29
4.4 Reducing Reintervention Rates 30
4.4.1 Controlled Drug Delivery Mechanisms 31
4.4.2 Improving Physician Training in Endovascular Techniques 31
5 Competitive Assessment 33
5.1 Market Share Analysis 33
5.1.1 North America 33
5.1.2 Europe 38
5.1.3 Asia-Pacific 41
5.1.4 South America 46
5.2 Key Companies and Product Profiles 50
5.2.1 Abbott Vascular 50
5.2.2 Biotronik 54
5.2.3 Boston Scientific 59
5.2.4 C.R. Bard 63
5.2.5 Cook Medical 66
5.2.6 Cordis (Cardinal Health) 70
5.2.7 Medtronic 72
5.2.8 Terumo 76
5.2.9 W.L. Gore 79
5.2.10 Other Players 82
5.3 Pipeline Products Assessment 89
6 Market Outlook 92
6.1 Procedure Trends 92
6.1.1 Treatment Paradigm 92
6.1.2 Lower Extremity Revascularization 93
6.1.3 Carotid Artery Stenting 99
6.1.4 Renal Artery Stenting 100
6.2 Global Market Drivers and Barriers 101
6.2.1 Driver: Rising Disease Prevalence 101
6.2.2 Driver: Rising Endovascular Procedure Rates 102
6.2.3 Driver: Improved Solutions for Superficial Femoral Artery Revascularization 102
6.2.4 Driver: Development of Low-profile Delivery Systems 103
6.2.5 Driver: Reduced Stent Fracture Rates with Second Generation Stents 104
6.2.6 Barrier: Impact of Current Reimbursement Schemes 104
6.2.7 Barrier: Lack of Rigorous Clinical Trials for Peripheral Bioabsorbable Stents 106
6.3 Market Outlooks by Segment 107
6.3.1 Global Overview 107
6.3.2 Lower Extremity Stents 109
6.3.3 Percutaneous Transluminal Angioplasty Balloons 112
6.3.4 Carotid Stents 114
6.3.5 Renal Stents 115
6.4 Market Outlooks by Geography 116
6.4.1 Global Overview 116
6.4.2 North America 119
6.4.3 Europe 123
6.4.4 Asia-Pacific 126
6.4.5 South America 129
7 Appendix 132
7.1 Bibliography 132
7.2 Abbreviations 146
7.3 Methodology 150
7.3.1 Overview 150
7.3.2 Coverage 150
7.3.3 Secondary Research 150
7.4 Forecasting Methodology 151
7.5 Physicians and Specialists Included in This Study 152
7.5.1 Key Opinion Leaders 152
7.6 Primary Research Summary 154
7.7 About the Authors 155
7.7.1 Analysts 155
7.7.2 Global Head of Medical Devices 155
7.7.3 About GlobalData 155
7.8 Disclaimer 156